Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome.

Jimenez-Vargas NN, Pattison LA, Zhao P, Lieu T, Latorre R, Jensen DD, Castro J, Aurelio L, Le GT, Flynn B, Herenbrink CK, Yeatman HR, Edgington-Mitchell L, Porter CJH, Halls ML, Canals M, Veldhuis NA, Poole DP, McLean P, Hicks GA, Scheff N, Chen E, Bhattacharya A, Schmidt BL, Brierley SM, Vanner SJ, Bunnett NW.

Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7438-E7447. doi: 10.1073/pnas.1721891115. Epub 2018 Jul 16.

2.

Forebrain neurone-specific deletion of insulin-regulated aminopeptidase causes age related deficits in memory.

Yeatman HR, Albiston AL, Burns P, Chai SY.

Neurobiol Learn Mem. 2016 Dec;136:174-182. doi: 10.1016/j.nlm.2016.09.017. Epub 2016 Oct 3.

PMID:
27713012
3.

Protein Kinase D and Gβγ Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane.

Jensen DD, Zhao P, Jimenez-Vargas NN, Lieu T, Gerges M, Yeatman HR, Canals M, Vanner SJ, Poole DP, Bunnett NW.

J Biol Chem. 2016 May 20;291(21):11285-99. doi: 10.1074/jbc.M115.710681. Epub 2016 Mar 30.

4.

Plasma membrane localization of the μ-opioid receptor controls spatiotemporal signaling.

Halls ML, Yeatman HR, Nowell CJ, Thompson GL, Gondin AB, Civciristov S, Bunnett NW, Lambert NA, Poole DP, Canals M.

Sci Signal. 2016 Feb 9;9(414):ra16. doi: 10.1126/scisignal.aac9177.

PMID:
26861044
5.

Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors.

Shang Y, Yeatman HR, Provasi D, Alt A, Christopoulos A, Canals M, Filizola M.

ACS Chem Biol. 2016 May 20;11(5):1220-9. doi: 10.1021/acschembio.5b00712. Epub 2016 Feb 17.

6.

A nutrient profiling assessment of packaged foods using two star-based front-of-pack labels.

Carrad AM, Louie JC, Yeatman HR, Dunford EK, Neal BC, Flood VM.

Public Health Nutr. 2016 Aug;19(12):2165-74. doi: 10.1017/S1368980015002748. Epub 2015 Sep 28.

PMID:
26411636
7.

Obesity framing for health policy development in Australia, France and Switzerland.

Patchett AD, Yeatman HR, Johnson KM.

Health Promot Int. 2016 Mar;31(1):83-92. doi: 10.1093/heapro/dau066. Epub 2014 Aug 21.

PMID:
25149100
8.

Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular trafficking.

Yeatman HR, Lane JR, Choy KH, Lambert NA, Sexton PM, Christopoulos A, Canals M.

J Biol Chem. 2014 May 30;289(22):15856-66. doi: 10.1074/jbc.M113.536672. Epub 2014 Apr 21.

9.

Health-related claims on food labels in Australia: understanding environmental health officers' roles and implications for policy.

Condon-Paoloni D, Yeatman HR, Grigonis-Deane E.

Public Health Nutr. 2015 Jan;18(1):81-8. doi: 10.1017/S1368980013003078. Epub 2013 Nov 20.

PMID:
24477275
10.

Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers.

Albiston AL, Diwakarla S, Fernando RN, Mountford SJ, Yeatman HR, Morgan B, Pham V, Holien JK, Parker MW, Thompson PE, Chai SY.

Br J Pharmacol. 2011 Sep;164(1):37-47. doi: 10.1111/j.1476-5381.2011.01402.x. Review.

11.

Distinct distribution of GLUT4 and insulin regulated aminopeptidase in the mouse kidney.

Albiston AL, Yeatman HR, Pham V, Fuller SJ, Diwakarla S, Fernando RN, Chai SY.

Regul Pept. 2011 Jan 17;166(1-3):83-9. doi: 10.1016/j.regpep.2010.09.003. Epub 2010 Sep 17.

PMID:
20851149
12.

Poor iodine status and knowledge related to iodine on the eve of mandatory iodine fortification in Australia.

Charlton KE, Yeatman HR, Houweling F.

Asia Pac J Clin Nutr. 2010;19(2):250-5.

13.

Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory.

Albiston AL, Fernando RN, Yeatman HR, Burns P, Ng L, Daswani D, Diwakarla S, Pham V, Chai SY.

Neurobiol Learn Mem. 2010 Jan;93(1):19-30. doi: 10.1016/j.nlm.2009.07.011. Epub 2009 Aug 4.

PMID:
19660563
14.

Reproduction and maternal behavior in insulin-regulated aminopeptidase (IRAP) knockout mice.

Pham V, Burns P, Albiston AL, Yeatman HR, Ng L, Diwakarla S, Chai SY.

Peptides. 2009 Oct;30(10):1861-5. doi: 10.1016/j.peptides.2009.07.019. Epub 2009 Aug 6.

PMID:
19647771
15.

Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase.

Chai SY, Yeatman HR, Parker MW, Ascher DB, Thompson PE, Mulvey HT, Albiston AL.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S14. doi: 10.1186/1471-2202-9-S2-S14. Review.

16.

Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase.

Albiston AL, Morton CJ, Ng HL, Pham V, Yeatman HR, Ye S, Fernando RN, De Bundel D, Ascher DB, Mendelsohn FA, Parker MW, Chai SY.

FASEB J. 2008 Dec;22(12):4209-17. doi: 10.1096/fj.08-112227. Epub 2008 Aug 20.

PMID:
18716029
17.

Women's awareness of the importance of long-chain omega-3 polyunsaturated fatty acid consumption during pregnancy: knowledge of risks, benefits and information accessibility.

Sinikovic DS, Yeatman HR, Cameron D, Meyer BJ.

Public Health Nutr. 2009 Apr;12(4):562-9. doi: 10.1017/S1368980008002425. Epub 2008 May 29.

PMID:
18507886
18.

Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails?

Albiston AL, Peck GR, Yeatman HR, Fernando R, Ye S, Chai SY.

Pharmacol Ther. 2007 Dec;116(3):417-27. Epub 2007 Aug 31. Review.

PMID:
17900701
19.

Supplemental Content

Loading ...
Support Center